Enumeral Biomedical

Enumeral, UMass Medical ink agreement

Thursday, August 27, 2015

Enumeral Biomedical Holdings has entered into a research study agreement with University of Massachusetts Medical School, which includes the institution’s clinical partner, UMass Memorial HealthCare. UMass Medical will provide Enumeral with tissue samples and blood samples from subjects with melanoma who are being treated with Ipilimumab (Yervoy). Enumeral will fund the tissue collection activities, and Enumeral will have access to the samples for research-only use in in-vitro studies.

[Read More]